MiniMed Group (NASDAQ:MMED) Stock Price Target Lowered at Barclays
Alpha Vantage · MarketBeat · · AI-summarised by FinFlash
Barclays lowered its MiniMed Group (NASDAQ:MMED) price target to $20.00 from $22.00 while keeping an "equal weight" rating, implying about 11.5% upside. The stock traded up 0.3% to Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.Understand the context